These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 16117149

  • 1. [Interferons beta in patients with multiple sclerosis].
    Vlasov IaV, Kuznetsova NI, Poverennova IE, Khivintseva EV.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):54-5. PubMed ID: 16117149
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [PRISMS study. Interferon beta-1a therapy in relapsing-remitting multiple sclerosis].
    Limmroth V.
    Internist (Berl); 2001 Feb; 42(2):305-7. PubMed ID: 11244885
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Interferon therapy of multiple sclerosis].
    Jensen D.
    Tidsskr Nor Laegeforen; 1999 Sep 10; 119(21):3142-5. PubMed ID: 10522481
    [Abstract] [Full Text] [Related]

  • 9. Depression in multiple sclerosis associated with interferon beta-1a (Rebif).
    Pandya R, Patten S.
    Can J Psychiatry; 2002 Sep 10; 47(7):686. PubMed ID: 12355685
    [No Abstract] [Full Text] [Related]

  • 10. Autoimmune hepatitis-like reaction developing in a patient treated with interferon-β1a.
    Mishra A, Guindi M, Kandel G, Streutker CJ.
    Histopathology; 2015 Mar 10; 66(4):605-7. PubMed ID: 24796493
    [No Abstract] [Full Text] [Related]

  • 11. Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.
    Trojano M, Liguori M, Paolicelli D, Zimatore GB, De Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P, Southern Italy MS Group.
    Mult Scler; 2003 Oct 10; 9(5):451-7. PubMed ID: 14582768
    [Abstract] [Full Text] [Related]

  • 12. Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.
    Río J, Tintoré M, Nos C, Téllez N, Galán I, Montalban X.
    J Neurol; 2005 Jul 10; 252(7):795-800. PubMed ID: 15772741
    [Abstract] [Full Text] [Related]

  • 13. [The use of rebif in the Moscow Municipal Multiple Sclerosis Center].
    Popova EV, Boĭko AN, Davydovskaia MF, Demina TL, Lashch NIu, Popova NF, Khachanova NV, Shchur SG, Gusev EI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011 Jul 10; 111(2 Pt 2):68-71. PubMed ID: 21916159
    [Abstract] [Full Text] [Related]

  • 14. The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
    Durelli L, Barbero P, Bergui M, Versino E, Bassano MA, Verdun E, Ferrero B, Rivoiro C, Ferrero C, Picco E, Ripellino P, Viglietti D, Giuliani G, Montanari E, Clerico M, OPTIMS Study Group.
    J Neurol; 2008 Sep 10; 255(9):1315-23. PubMed ID: 18825438
    [Abstract] [Full Text] [Related]

  • 15. Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
    Singer B, Bandari D, Cascione M, LaGanke C, Huddlestone J, Bennett R, Dangond F, REFORMS Study Group.
    BMC Neurol; 2012 Dec 06; 12():154. PubMed ID: 23216674
    [Abstract] [Full Text] [Related]

  • 16. Improving the convenience of home-based interferon beta-1a therapy for multiple sclerosis.
    Lesaux J, Jadbäck G, Harraghy CE.
    J Neurosci Nurs; 1999 Jun 06; 31(3):174-9. PubMed ID: 10846648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Spotlight on subcutaneous recombinant interferon-beta-1a (Rebif) in relapsing-remitting multiple sclerosis.
    Murdoch D, Lyseng-Williamson KA.
    BioDrugs; 2005 Jun 06; 19(5):323-5. PubMed ID: 16207073
    [Abstract] [Full Text] [Related]

  • 19. Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis.
    Serarslan G, Okuyucu E, Melek I, Hakverdi S, Duman T.
    Mult Scler; 2008 Mar 06; 14(2):259-61. PubMed ID: 18337427
    [Abstract] [Full Text] [Related]

  • 20. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
    Togha M, Karvigh SA, Nabavi M, Moghadam NB, Harirchian MH, Sahraian MA, Enzevaei A, Nourian A, Ghanaati H, Firouznia K, Jannati A, Shekiba M.
    Mult Scler; 2010 Jul 06; 16(7):848-54. PubMed ID: 20488825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.